Current population · 2,231
Understanding the treatment benefit of hyperimmune anti-influenza intravenous...
Vanderven HA, Wentworth DN, Han WM, Peck H, Barr IG, Davey RT Jr, Beigel JH, ...
← ExplorerSource ↗Publication identity
Publication IDCPD-1970
Year2023
PMID37289541
DOI10.1172/jci.insight.167464
JournalJCI Insight
AuthorsVanderven HA, Wentworth DN, Han WM, Peck H, Barr IG, Davey RT Jr, Beigel JH, ...
First authorVanderven HA
Senior authorKent SJ; INSIGHT FLU-IVIG Study Group
Scientific classification
Research themeCOVID-19 / respiratory viruses; Clinical infectious diseases
Pathogen groupInfluenza / respiratory viruses
Technology / methodSerology / immunology; Clinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceDwyer DE
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/37289541/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →